PIK3CD and hepatocellular carcinoma: The inhibition of the PI3K pathway was among the mechanisms involved in the anticancer activities of epigallocatechin gallate, quercetin, and apigenin in the T47D and HFF cells, the human hepatoma cell line, and the T24 cell line, respectively (Kopustinskiene et al. 2020).